These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 18245142

  • 1. Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD.
    Singh D, Brooks J, Hagan G, Cahn A, O'Connor BJ.
    Thorax; 2008 Jul; 63(7):592-8. PubMed ID: 18245142
    [Abstract] [Full Text] [Related]

  • 2. Benefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPD.
    Hanania NA, Crater GD, Morris AN, Emmett AH, O'Dell DM, Niewoehner DE.
    Respir Med; 2012 Jan; 106(1):91-101. PubMed ID: 22040533
    [Abstract] [Full Text] [Related]

  • 3. Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone.
    Kurashima K, Hara K, Yoneda K, Kanauchi T, Kagiyama N, Tokunaga D, Takayanagi N, Ubukata M, Sugita Y.
    Respirology; 2009 Mar; 14(2):239-44. PubMed ID: 19210650
    [Abstract] [Full Text] [Related]

  • 4. Effects of tiotropium and salmeterol/fluticasone propionate on airway wall thickness in chronic obstructive pulmonary disease.
    Hoshino M, Ohtawa J.
    Respiration; 2013 Mar; 86(4):280-7. PubMed ID: 23880883
    [Abstract] [Full Text] [Related]

  • 5. Triple therapy with salmeterol/fluticasone propionate 50/250 plus tiotropium bromide improve lung function versus individual treatments in moderate-to-severe Japanese COPD patients: a randomized controlled trial - Evaluation of Airway sGaw after treatment with tripLE.
    Saito T, Takeda A, Hashimoto K, Kobayashi A, Hayamizu T, Hagan GW.
    Int J Chron Obstruct Pulmon Dis; 2015 Mar; 10():2393-404. PubMed ID: 26604737
    [Abstract] [Full Text] [Related]

  • 6. A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma.
    Fardon T, Haggart K, Lee DK, Lipworth BJ.
    Respir Med; 2007 Jun; 101(6):1218-28. PubMed ID: 17178217
    [Abstract] [Full Text] [Related]

  • 7. Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: a pilot study.
    Bateman ED, van Dyk M, Sagriotis A.
    Pulm Pharmacol Ther; 2008 Jun; 21(1):20-5. PubMed ID: 17118684
    [Abstract] [Full Text] [Related]

  • 8. Effects of tiotropium or combined therapy with salmeterol on hyperinflation in COPD.
    Eguchi Y, Tateishi Y, Umeda N, Yoshikawa T, Kamoi H, Kanazawa H, Kudoh S, Hirata K, Fujimoto S.
    Osaka City Med J; 2007 Jun; 53(1):25-34. PubMed ID: 17867631
    [Abstract] [Full Text] [Related]

  • 9. Effects of adding salmeterol/fluticasone propionate to tiotropium on airway dimensions in patients with chronic obstructive pulmonary disease.
    Hoshino M, Ohtawa J.
    Respirology; 2011 Jan; 16(1):95-101. PubMed ID: 20920142
    [Abstract] [Full Text] [Related]

  • 10. Comparison of tiotropium plus fluticasone propionate/salmeterol with tiotropium in COPD: a randomized controlled study.
    Jung KS, Park HY, Park SY, Kim SK, Kim YK, Shim JJ, Moon HS, Lee KH, Yoo JH, Lee SD, Korean Academy of Tuberculosis and Respiratory Diseases study group, Korea Chronic Obstructive Pulmonary Disease study group.
    Respir Med; 2012 Mar; 106(3):382-9. PubMed ID: 21975275
    [Abstract] [Full Text] [Related]

  • 11. [Combination of inhaled salmeterol/fluticasone and tiotropium in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial].
    Fang LZ, Liang X, Zhang JQ, Liu L, Fu WP, Zhao ZH, Dai LM.
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov; 31(11):811-4. PubMed ID: 19080533
    [Abstract] [Full Text] [Related]

  • 12. Tiotropium and salmeterol/fluticasone combination do not cause oxygen desaturation in COPD.
    Andò F, Ruggeri P, Girbino G, Cazzola M.
    Respir Med; 2008 Jun; 102(6):815-8. PubMed ID: 18343646
    [Abstract] [Full Text] [Related]

  • 13. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
    Lindberg A, Szalai Z, Pullerits T, Radeczky E.
    Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063
    [Abstract] [Full Text] [Related]

  • 14. Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease.
    Vestbo J, Pauwels R, Anderson JA, Jones P, Calverley P, TRISTSAN study group.
    Thorax; 2005 Apr; 60(4):301-4. PubMed ID: 15790985
    [Abstract] [Full Text] [Related]

  • 15. EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma.
    Dahl R, Chuchalin A, Gor D, Yoxall S, Sharma R.
    Respir Med; 2006 Jul; 100(7):1152-62. PubMed ID: 16675212
    [Abstract] [Full Text] [Related]

  • 16. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B, Dhembare P, Jantikar A, Mahadik P, Gokhale P, Gogtay JA, Salvi SS.
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [Abstract] [Full Text] [Related]

  • 17. Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations.
    Ferguson GT, Anzueto A, Fei R, Emmett A, Knobil K, Kalberg C.
    Respir Med; 2008 Aug; 102(8):1099-108. PubMed ID: 18614347
    [Abstract] [Full Text] [Related]

  • 18. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
    Balkissoon R, Make B.
    COPD; 2008 Aug; 5(4):221-7. PubMed ID: 18671147
    [Abstract] [Full Text] [Related]

  • 19. Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial.
    Wouters EF, Postma DS, Fokkens B, Hop WC, Prins J, Kuipers AF, Pasma HR, Hensing CA, Creutzberg EC, COSMIC (COPD and Seretide: a Multi-Center Intervention and Characterization) Study Group.
    Thorax; 2005 Jun; 60(6):480-7. PubMed ID: 15923248
    [Abstract] [Full Text] [Related]

  • 20. A pilot study to assess the effects of combining fluticasone propionate/salmeterol and tiotropium on the airflow obstruction of patients with severe-to-very severe COPD.
    Cazzola M, Andò F, Santus P, Ruggeri P, Di Marco F, Sanduzzi A, D'Amato M.
    Pulm Pharmacol Ther; 2007 Jun; 20(5):556-61. PubMed ID: 16914336
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.